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Background: Psychiatric comorbidities are prevalent in patients with chronic somatic disorders such as asthma. But,
there is no clear evidence regarding the effect of atopic status and the type of sensitized allergen on emotional
status. The aim of the present study was to investigate the effects of house dust mites and pollen allergies on
emotional status, asthma control and the quality of life in patients with atopic asthma.
Methods: The study included 174 consecutive patients who were diagnosed with asthma accoring to the GINA
criteria and who did not receive therapy for their allergy. All patients underwent a skin prick test. The asthma
control, quality of life, and emotional status were evaluated using the ACT (asthma control test), AQLQ
(asthma-specific quality of life questionnaire), and HAD (hospital anxiety depression questionnaire).
Results: Atopy was detected in 134 (78.7%) patients. Of those patients: 58 (33.3%) had anxiety and 83 (47.7%) had
depression. There was no relationship between emotional status, atopic status, and the type of indoor/outdoor
allergen. Furthermore, there was no relationship between atopy and asthma severity, asthma control, and the
quality of life. The anxiety and depression scores were significantly higher and the quality of life scores lower in the
uncontrolled asthma group. The ACT and AQLQ scores were also lower in the anxiety and depression groups.
Conclusions: It was concluded that anxiety and depression are prevalent in patients with uncontrolled asthma, and
atopic status did not affect the scores in ACT, AQLQ, and emotional status tests.
Keywords: Atopy, Asthma control, Quality of life, Emotional status, Depression, AnxietyIntroduction
Asthma is a chronic health problem that encompasses
the patient’s entire lifetime, and causes significant mental
and social problems in addition to physical symptoms. It
is; therefore, considerably important to evaluate the qual-
ity of life of the patients in addition to the symptoms in
order to gather full information about the health status of
the patients [1].
Psychiatric comorbidities are frequently observed in pa-
tients suffering from chronic somatic disorders. These psy-
chiatric comorbidities have a significant negative impact on
the quality of life of the patients [1]. Emotional disorders,
including anxiety and depression are more prevalent in
asthma as compared to the general population [2-4]. Based* Correspondence: dryaydemir@yahoo.com
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article, unless otherwise stated.on review of the literature, the prevalence of anxiety and
psychological disorders among bronchial asthma patients
can be estimated at 30–52% [5-7]. Similarly, high frequency
of anxiety and depression has been demonstrated in atopic
patients [8,9]. In that case, the association of asthma and
the atopic trait further can contribute to the impairment in
emotional status as compared to non-atopic patients with
asthma. Also it can be a relationship between the type of
allergen and emotional status. These last two topics have
not yet sufficiently clear.
The allergens are well-known to cause asthma exacer-
bations and sustained symptoms [10]; however, there are
still very few data regarding the effects of allergens on
asthma control, quality of life, and emotional status. To
our knowledge, there is no study that evaluated the rela-
tionship between the type of internal and external the al-
lergens and emotional status.Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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emotional status of patients with asthma. Main purpose of
our study was to investigate the effects of house dust mites
and pollen allergies on emotional status, asthma control
and the quality of life in patients with atopic asthma.
Materials and methods
The consecutive 174 patients, who were new diagnosed
with asthma according to GINA criteria in Sakarya
University Hospital (Turkey) in March-September 2012
period and who have not received at least last one
month an antihistamines and immunotherapy for allergy
and any inhaled or oral therapy for asthma were included
in the present study. The patients who were receiving a
therapy for psychiatric disease or those with a chronic dis-
order (chronic obstructive pulmonary disease, diabetes,
coronary artery disease, malignancy) that could affect
emotional status were excluded from the study.
A detailed medical history was obtained, and all pa-
tients underwent physical examinations. All pulmonary
function tests were performed by the same technician
on the SpiroAnalyser ST-300 instrument. The severity of
asthma was determined based on Global Initiative for
Asthma (GINA) criteria [1]. The patients, who provided
informed consent, were included in the study, and the
questionnaire form evaluating the demographic charac-
teristics, anthropometric measurements, and the features
of the asthma were administered to all patients. All pa-
tients filled out the ACT (asthma control test), AQLQ
(asthma quality of life questionnaire) (Turkish version)
and HAD (Hospital Anxiety and Depression) (Turkish
version) surveys and the results were recorded on the
questionnaire form. An approval was obtained from the
university ethics committee.
Assessment of asthma control
The patients were administered a 5-item questionnaire
assessing their asthma symptoms, use of rescue medica-
tions, and the impact of asthma on daily life [11]. In
asthma control test, a score of 25 points indicated full
control, 20–24 points indicated controlled disease, 16–19
points indicated partial control, and score below 15 indi-
cated uncontrolled disease. In statistical analysis, patients
achieving a score higher than 20 were assessed as a single
group (control and full control), and patients achieving a
score lower than 19 were assessed as a separate group
(partial control and uncontrolled). The validity and reli-
ability of this questionnaire has been previously shown in
adult Turkish patients with asthma [12].
Assessment of the quality of life
The AQLQ assessed the scores of the patients regarding
their symptoms (12 questions), restriction of activity
(11 questions), emotional function (5 questions), andenvironmental exposure (4 questions). The total score
was recorded as the average of the scores in 32 ques-
tions [13]. The answers to each question are scored one
to seven (1 =maximum impairment and 7 = no impair-
ment). Scoring domains were expressed as the mean
score per question. Low scores indicate a poor quality of
life.The validity and reliability of this questionnaire has
been previously shown in adult Turkish patients with
asthma [14].
Assessment of emotional status
The assessment of emotional status was measured by
using the HAD questionnaire. The Hospital Anxiety and
Depression Scale was developed in 1983 by the Zigmond
and Snaith and the validity and reliability were per-
formed [15]. It includes the subscales of anxiety and de-
pression. This scale consisted of a total of 14 questions:
7 of them investigated the symptoms of depression, and
7 of them investigated the symptoms of anxiety. The
answers were evaluated in the form of a four-point
Likert type scale. The scale was scored between 0 (best)
and 3 (worst).
The purpose of the scale is not to diagnose, but to de-
termine the risk group by scanning anxiety and depres-
sion in physically ill patients in a short amount of time.
The scale can also be used in the follow up of changes
in the patient’s emotional state. Although the scale uses
the word “hospital”, it can also be used in the field or in
a study performed in outpatient settings. To the aim was
to minimize the effects of the existing somatic disease
on the scale results in the HAD scale.
For this reason, it does not include any physical signs.
In the preparation of scoring, “0 to 1” was recognized as
normal, “2” was recognized as borderline symptomatic,
and “3” was recognized as having prominent symptoms.
It has been proven that the HAD scale is a useful assess-
ment tool, and its score range provides results so as to
minimize the false-positive and false-negative data [16].
It has been shown that scores obtained from the scale
are not affected by the presence of somatic disease [16].
The HAD scale was used in comparison with other
scales and was found to be adequate in terms of the
evaluation of anxiety and depression in patients with
somatic diseases [17].
Turkish adaptation study of HAD scala has been made
by Aydemir et al. According to this study, for the anxiety
sub-scale cut-off score has been found 10 and more, and
depression subscale cut-off score has been found 7 and
more [18]. Measurements displayed that the limit value
for anxiety was 10 or higher, while the limit value for de-
pression was 7 or higher. It was evaluated that an anx-
iety score greater than 10 was HAD-A (+), under 10 was
HAD-A (−), and those having depression scores over 7
were HAD-D (+), while those under 7 were HAD-D (−).
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A skin test (ALK-Abello, Madrid, Spain) was performed
using 20 different aeroallergens in order to determine
atopic status of the patients. The test media contained a
mixture of Dermatofagoides farinea, D. pteronyssinus,
storage mite, cockroaches, latex, hair, fungi, wheat, oak,
olive, trees, mixture of weeds, cat hair, dog hair, grass
mixture, and grass-wheat mixture. Histamine was used
as a positive control and saline was used as a negative
control. The test site was evaluated after 15 minutes,
and the result was considered positive if the edema was
more than 3 mm in diameter. The house dust mites were
considered indoor allergen, and pollens were considered
outdoor allergen (trees, mixture of weed, mixture of grass,
grass-wheat mixture).
Statistical analysis
The SPSS for Windows 21.0 (IBM) software package
was used in the statistical analysis of the study. In the
present study, the continuous variables were expressed
with mean value, standard deviation, maximum and mini-
mum values. The Shapiro-Wilk test was used for the nor-
mality test of continuous variables. Normally distributed
continuous variables were compared by means of variables
were evaluated with samples t test, nonparametric variables
between the two groups were made by Mann–Whitney
U test, categorical variables were compared by Chi
square test.
Results
Sociodemographic features and general characteristics of
asthma
A total of 174 patients were included in the study. The






Mean ± sd Min/max
Age 43.8 ± 13 18/72
BMI (kg/m2) 27.49 ± 5.2 17.70/49.30
FVC (%) 84.9 ± 16.5 23/129
FEV1 (%) 84.7 ± 19.3 19/125
FEV1/FVC (%) 84.4 ± 9.6 48/110
PEF (%) 67.4 ± 18.7 12/111
ACT 18.3 ± 5.1 5/25
AQLQ Total 4.3 ± 1.2 1.18/6.84
BMI: Body Mass Index; FVC: Forced Expiratory Volume; FEV1: Forced Expiratory
Volume in 1.second; PEF: Peak Expiratory Volume; ACT: Asthma Control Test
score; AQLQ; Asthma Quality of Life Questionnaire score.The prevalance of allergy and psychiatric disorders
The skin prick test was found to be positive for at least
one allergen in 137 patients (78.7%), with 45 patients
(25.9%) having only a pollen allergy, 32 patients (18.4%)
having only a mite allergy, and 60 patients (34.5%) hav-
ing both pollen and mite allergies. In total, 105 patients
(60.3%) had pollen allergies and 92 patients (52.9%) had
mite allergies.
The mean anxiety score was 8.07 + 4.42, the mean
depression score was 7.00 + 4.54, and the mean HAD
score was 15.07 + 7.97. When the cutoff for anxiety and
depression was taken as 10 and 7, respectively, 58
patients (33.3%) had anxiety, and 83 patients (47.7%)
had depression.
ACT and AQLQ status
The mean ACT score was 18.32 + 5.1. Of the patients,
19 (10.9%) had fully controlled disease, 65 (32.4%) had
controlled disease, 78 (44.8%) had partially controlled dis-
ease, and 12 (6.9%) had uncontrolled disease. When the
cut-off for asthma control was taken as 20, 89 patients
(51.1%) had uncontrolled asthma, and 85 patients (48.9%)
had controlled asthma.
The mean total AQLQ score was 4.30 + 1.24, the mean
symptom score was 4.76 + 1.38, the mean activity score
was 4.04 + 1.27, the mean emotional score was 4.50 +
1.57, and the mean environmental exposure score was
3.61 + 1.64.
The relationship between allergic status and ACT, AQLQ,
and emotional status
There was no significant difference between patients who
had versus who did not have mite and pollen allergy in
terms of asthma control, quality of life, anxiety, and de-
pression level (Table 2).
Of the patients, 105 had pollen allergies, 92 had mite al-
lergies, and 60 had both mite and pollen allergies. When
analyzed by the type of allergens, there was no significantTable 2 The relationship between atopy and emotional
status, quality of life, and asthma control
Mean (SD) Non-atopic




HAD-Anxiety 8.43 (4.35) 7.98 (4.45) 0.607
HAD-Depression 7.57 (4.52) 6.85 (4.43) 0.277
HAD- Total 16.00 (7.51) 14.82 (8.10) 0.302
ACT 17.97 (4.89) 18.42 (5.18) 0.486
AQLQ-Total 4.45 (1.24) 4.29 (1.24) 0.683
AQLQ-Symptom 4.90 (1.34) 4.72 (1.39) 0.550
AQLQ-Activity 4.10 (1.35) 4.02 (1.25) 0.855
AQLQ-Emotional 4.63 (1.49) 4.47 (1.59) 0.771
HAD: Hospital Anxiety Depression Score; ACT: Asthma Control Test score;
AQLQ; Asthma Quality of Life Questionnaire score.
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iety, and depression level (Table 3).
The relationship between emotional status and ACT and
AQLQ
Independent from the type of allergen, the patients with
an anxiety score greater than 10 and depression score
greater than 7 had significantly worse asthma control and
lower quality of life (Table 4).
The relationship between allergic status and general
patient characteristics
Atopic patients did not significantly differ in terms of spi-
rometric measurements, BMI, age of asthma, and number
of exacerbations; however, prick test positivity was signifi-
cantly higher among male patients with rhinitis (Table 5).
The relationship between emotional status and general
patient characteristics
The general characteristics and spirometric measurements
were comparable between the two groups. The number of
episodes was the only parameter that differed between pa-
tients with and without anxiety (p = 0.039), while the num-
ber of episodes (p = 0.002), and asthma severity (p = 0.013),
were the two parameters that significantly differed between
patients with and without depression.
The relationship between asthma control status and
emotional status
The patients with uncontrolled asthma achieved signifi-
cantly worse scores in emotional status and quality of
life domains (Table 6).
Discussion
The present study evaluated the effects of the atopic
trait and the type of allergy on the level of anxiety,
depression, quality of life, and asthma control. When
atopic patients with positive skin prick test were com-
pared to non-atopic patients, no significant difference
was found in terms of anxiety and depression scores,
asthma control, and quality of life. There was also noTable 3 The relationship between the type of allergy and em
Mean (SD) Pollen allergy
Absent n = 69 Present n = 105 p v
HAD-A 8.43 (4.42) 7.84 (4.42) 0.32
HAD-D 7.12 (4.31) 6.92 (4.56) 0.56
HAD-T 15.48 (7.83) 14.80 (8.07) 0.41
ACT 17.87 (5.34) 18.62 (4.95) 0.39
AQLQ-T 4.36 (1.32) 4.30 (1.19) 0.67
HAD-A: Hospital Anxiety Depression Scales Anxiety score; HAD-D: Hospital Anxiety D
total score. ACT: Asthma Control Test score; AQLQ; Asthma Quality of Life Questionsignificant difference in terms of the types of pollen and
mite allergies.
The exposure to allergens is a well-established cause
of asthma episodes and sustained symptoms in atopic
patients [19,20]. In this case, atopic patients can be ex-
pected to have lower symptom scores and quality of life
score, and hence higher anxiety-depression scores. This
is due to the fact that anxiety and depression was shown
to correlate with disease control [6,21-23]. However, the
results provided evidences contrary to this hypothesis.
As a matter of fact, whether atopy is associated with
increased asthma control is a topic that has not been
fully elucidated. In a study that evaluated atopic trait in
asthma, no significant difference was found between
atopic and non-atopic patients in terms of asthma symp-
toms, quality of life, hospitalizations, and admission to
emergency room [24]. Both groups were found to be simi-
lar with regards to asthma severity [25]. In the present
study, there was no significant difference between atopic
and non-atopic patients in terms of asthma control, fre-
quency of asthma episodes, asthma severity and spiromet-
ric measurements.
The major strength of the present study was its cross-
sectional design and inclusion of patients with a recent
diagnosis that have not received a previous allergic ther-
apy. In studies that are based on the review of patient
charts, treatment effect appears as a confounder, in that,
therapy may have minimized the effects of allergy. Con-
sequently, the studies that evaluated the effects of ther-
apy have shown improvement in the quality of life score
after the therapy in comparison to pre-treatment scores
[26]. Another study reported a significant improvement
in the quality of life of patients with house mite allergy
that underwent immunotherapy [27].
There are a very limited number of studies in the litera-
ture regarding allergic sensitization and emotional status.
Among these studies, Kohlbeck evaluated 182 atopic and
63 non-atopic children with asthma and reported a 3-fold
higher rate of emotional disorders in the asthma group.
Similarly to the present study, they did not find any sig-
nificant differences between atopic asthma group and
non-atopic group. In addition, they did not report aotional status, quality of life, and asthma control
Mite allergy
alue Absent n = 82 Present n = 92 p value
7 7.80 (4.27) 8.32 (4.56) 0.444
1 7.11 (4.28) 6.90 (4.62) 0.486
8 14.94 (7.59) 15.18 (8.33) 0.947
2 18.51 (4,98) 18.15 (5.24) 0.757
5 4.52 (1.20) 4.15 (1.26) 0.099
epression Scales Depression score; HAD-T: Hospital Anxiety Depression Scales
naire score.
Table 4 The relationship between emotional status and the quality of life and asthma control
Mean (SD) Anxiety Depression
Absent n = 116 Present n = 58 p value Absent n = 91 Present n = 83 p value
ACT 19.28 (4.82) 16.41(5.17) <0.001 20.18 (4.29) 16.20 (5.19) <0.001
AQLQ-Total 4.68 (1.11) 3.62 (1.20) <0.001 4.80 (1.07) 3.81 (1.21) <0.001
AQLQ-Symptom 5.10 (1.21) 4.07 (1.46) <0.001 5.27 (1.14) 4.20 (1.41) <0.001
AQLQ-Activity 4.31 (1.24) 3.49 (1.15) <0.001 4.44 (1.21) 3.59 (1.18) <0.001
AQLQ-Emotion 5.08 (1.28) 3.36 (1.47) <0.001 5.08 (1.33) 3.88 (1.58) <0.001
AQLQ-Environ. 3.92 (1.63) 3.00 (1.48) <0.001 4.03 (1.59) 3.16 (1.58) <0.001
Asthma severity 1.91 (1.04) 2.21 (1.07) 0.196 1.81 (0.98) 2.22 (1.10) 0.045
ACT: Asthma Control Test; AQLQ; Asthma Quality of Life Questionnaire score. Environ: environmental.
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BMI, and frequency of rhinitis [28].
In the study by Barone et al. that evaluated 217 pa-
tients, the total Anxiety Sensitivity Index score was sig-
nificantly higher in the atopic group when compared to
the non-atopic group; however, no significant differences
were found between atopic and non-atopic asthmatics in
terms of their scores in Beck Depression Inventory-II.
The spirometric measurements and severity of asthma
were comparable between the two groups [29].
As a secondary outcome of the present study, ACT
and ACLQ scores were found to be significantly lower in
patients with anxiety and depression. Our study confirmed
that both the prevalence and severity of emotional disor-
ders are related to the degree of asthma control and qual-
ity of life. These results are consistent with the works of
other authors. Janson observed a correlation between the
prevalence of anxiety and depression and the occurrence
of asthma symptoms. [30] In another study, anxiety and
depression were more frequent among patients with
“difficult” asthma [5]. In the study by Trzcińska et al., the
prevalence of depression and its severity were significantly
correlated with the degree of asthma control [6]. TheTable 5 The relationship between atopic trait and various
patient characteristics
Mean (SD) Non-atopic




Age 46.73 (11.82) 43.06 (13.27) 0.138
Gender (f/m) 34/3 100/37 0.016




FVC (% ) 85.78 (15.59) 84.65 (16.81) 0.551
FEV1 (%) 85.14 (18.93) 84.79 (19.54) 0.854
PEF (%+) 67.46 (17.48) 67.3 (19.05) 0.760
Exacerbation/year 0.35 (0,6) 0.66 (1.61) 0.868
Asthma severity 2.05 (0,9) 1.99 (1,09) 0.142
BMI: Body Mass Index; FVC: Forced Expiratory Volume; FEV1: Forced Expiratory
Volume in 1.second; PEF: Peak Expiratory Volume.results of Di Marco’s study show a significant correl-
ation between poor level of asthma control and both
anxiety (OR: 3.76) and depression (OR: 2.45), which are
frequent disorders in asthmatic subjects [23]. The neuro-
physiological mechanism of the relationship between de-
pression and asthma has been evidenced in the previous
studies [31,32].
Is the asthma control and quality of life worse in those
with a psychiatric disorder, or may it be that emotional
status is worse in patients with uncontrolled asthma?
There is not a straightforward answer to this question as
the present study has not been designed as to address
this casual relationship. Age, BMI, presence of rhinitis,
and as the basic parameters of asthma FEV1, FVC, and
PEF values were similar in patients with anxiety and de-
pression. However, the number of exacerbations were
higher in the anxiety group, and the number of exacerba-
tions and asthma severity were higher in the depression
group. This discrepancy complicates the interpretation of
the results. If these parameters were similar between the
groups, this would provide convincing evidence that emo-
tional status has negative effects on asthma control and
the quality of life. In our opinion, anxiety and depression
are more common in uncontrolled asthma group and the
statistical significance of this relationship is stronger.Table 6 The relationship between ACT score and HAD-A
and HAD-D
Mean (SD) Uncontrolled asthma
(ACT < 20) n:89
Controlled asthma
(ACT ≥ 20) n:85
P value
HAD-A 9.18 (4.40) 6.92 (4.16) 0.001
HAD-A≥ 10
n (%)
37 (41,6) 21 (24.7) -
HAD-D 8.27 (4.18) 5.67 (4.36) <0.001
HAD-D≥ 7
n (%)
54 (60.7) 29/85 (34.1) -
HAD-T 17.42 (7.81) 12.61 (7.41) <0.001
AQLQ 5.01 (1.13) 3.67 (0.95) <0.001
HAD-A: Hospital Anxiety Depression Scales Anxiety score; HAD-D: Hospital Anxiety
Depression Scales Depression score; HAD-T: Hospital Anxiety Depression Scales
total score; AQLQ; Asthma Quality of Life Questionnaire score.
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ders are the result of poor asthma control.
Of the patients in the study group, 78.7% had rhinitis.
The prevalenece of house dust mite and pollen allergy
was higher in patients with rhinitis. Only 18 patients
(13%) had rhinitis combined with a negative prick test.
Consistent with the current results, previous studies
reported a rate of positive prick test in patients with al-
lergic rhinitis that ranged from 81% to 62.5% [33-35].
No relationship was observed between rhinitis and emo-
tional status.
Another major strength of the study is the use of ob-
jective skin prick tests to determine atopic status. And
these tests were conducted at the same time with the
asthma control, quality of life and psychological status
evaluation.
Our study has its limitations; firstly, we used question-
naires to evaluate emotional status, and no actual phys-
ician diagnosis was used. Secondly, this study was a
single center study, and it is not capable of evaluating
various ethnic and sociocultural differences, thus pre-
venting the generalized use of the study results.
The present study is the first, to our knowledge, to
systematically investigate the association between emo-
tional status, quality of life, and indoor-outdoor type of
atopy in patients with asthma. Finally, it was concluded
that house dust mite and pollen allergies did not influ-
ence the scores in ACT and AQLQ; therefore, they did
not increase the prevalence of anxiety and depression. It
was concluded that emotional impairment is prevalent
in patients with uncontrolled asthma, and holistic treat-
ment approach should include psychological support
and patient education in addition to the provision of
medical therapy.Competing interests
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